Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psoriatic Subjects”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04109976
What this trial is testing

Evaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-injector for the Subcutaneous Self-injection of Bimekizumab Solution by Subjects With Active Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
UCB Biopharma SRL 214
Post-approval studies (Phase 4)UnknownNCT01939132
What this trial is testing

Protocol for H.P. Acthar Gel in Moderately to Severely Active Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Fiechtner, Justus J., M.D., P.C. 10
Large-scale testing (Phase 3)Active Not RecruitingNCT03675308
What this trial is testing

A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy

Who this might be right for
Psoriatic Arthritis
AbbVie 964
Large-scale testing (Phase 3)Study completedNCT03896581
What this trial is testing

Evaluate the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
UCB Biopharma SRL 400
Post-approval studies (Phase 4)Study completedNCT04183881
What this trial is testing

Clinical Study of Brodalumab

Who this might be right for
Psoriasis VulgarisPsoriatic ArthritisPustular; Psoriasis, Palmaris Et Plantaris+1 more
Kyowa Kirin Co., Ltd. 138
Testing effectiveness (Phase 2)Study completedNCT03347110
What this trial is testing

Evaluate the Long-Term Safety and Efficacy of Bimekizumab in Subjects With Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
UCB Biopharma SRL 184
Large-scale testing (Phase 3)Study completedNCT01882439
What this trial is testing

Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors

Who this might be right for
Psoriatic Arthritis
Pfizer 395
Large-scale testing (Phase 3)Study completedNCT01212757
What this trial is testing

PALACE 2: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Amgen 488
Early research (Phase 1)Study completedNCT06291948
What this trial is testing

A Clinical Study With Adalimumab Biosimilar

Who this might be right for
PharmacokineticsSafety Issues
Laboratorios Richmond S.A.C.I.F. 150
Large-scale testing (Phase 3)Ended earlyNCT01230827
What this trial is testing

The Safety and Efficacy of CNTO 148 (Golimumab) in Children With Juvenile Idiopathic Arthritis (JIA) and Multiple Joint Involvement Who Have Poor Response to Methotrexate (GO KIDS)

Who this might be right for
Juvenile Idiopathic Arthritis
Janssen Research & Development, LLC 173
Large-scale testing (Phase 3)Looking for participantsNCT06671483
What this trial is testing

Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines

Who this might be right for
Psoriatic Arthritis
Takeda 1,088
Large-scale testing (Phase 3)Looking for participantsNCT06671496
What this trial is testing

Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines

Who this might be right for
Psoriatic Arthritis
Takeda 600
Post-approval studies (Phase 4)Study completedNCT03783026
What this trial is testing

Evaluate the Impact of Apremilast on Magnetic Resonance Imaging (MRI) Outcomes in Adults With Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Amgen 123
Large-scale testing (Phase 3)Study completedNCT04314544
What this trial is testing

Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1)

Who this might be right for
Active Psoriatic Arthritis
Sun Pharmaceutical Industries Limited 508
Early research (Phase 1)Study completedNCT02141763
What this trial is testing

Multiple Dose Study of UCB4940 in Subjects With Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
UCB Celltech 53
Testing effectiveness (Phase 2)Study completedNCT01116895
What this trial is testing

A Proof of Concept Study Comparing Three Doses of an Oral Solution of LEO 22811 With a Placebo Oral Solution for the Treatment of Psoriasis Vulgaris

Who this might be right for
Psoriasis Vulgaris
LEO Pharma 63
Early research (Phase 1)Study completedNCT03262727
What this trial is testing

The Effect of BMS-986165 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Patients

Who this might be right for
Systemic Lupus ErythematosusArthritic PsoriasisPsoriasis+1 more
Bristol-Myers Squibb 49
Testing effectiveness (Phase 2)Study completedNCT02349451
What this trial is testing

Investigate the Safety, Tolerability and Efficacy of ABT-122 in Subjects With Active Psoriatic Arthritis (PsA) Who Have an Inadequate Response to Methotrexate (MTX)

Who this might be right for
Psoriatic Arthritis
AbbVie 240
Testing effectiveness (Phase 2)Study completedNCT00646386
What this trial is testing

Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Moderately to Severely Active Psoriatic Arthritis

Who this might be right for
ArthritisPsoriatic
Abbott 315
Large-scale testing (Phase 3)Study completedNCT03486457
What this trial is testing

Efficacy And Safety Of Tofacitinib In Chinese Subjects With Active Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Pfizer 204
Next Page